1. Stocks
  2. Atara Biotherapeutics Inc
  3. Swot
swot-logo

Atara Biotherapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Atara Biotherapeutics Inc has 11 Strengths, 9 Weaknesses, 3 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Stock gained more than 20% in one month

Stock with Low PE (PE < = 10)

Highest Recovery from 52 Week Low

Promoter decreasing their shareholding

Stocks with Quarter Change % less than Industry

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Top Losers

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Stocks rising sharply on very low month volumes

Mutual Funds Decreased Shareholding in Past Month

Institutions decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks